CXCR2 and cancer: Importantly, the increase in the expression of CXCL1 and other CXCR2 ligands may not be a mechanism of chemoresistance but only a marker of chemoresistance in some cancers associated with the induction of TNF-α expression by chemotherapeutics, e.g., docetaxel [142].